Working… Menu
Trial record 1 of 1 for:    CYD50
Previous Study | Return to List | Next Study

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02741128
Recruitment Status : Active, not recruiting
First Posted : April 18, 2016
Last Update Posted : February 16, 2021
Information provided by (Responsible Party):
Sanofi ( Sanofi Pasteur, a Sanofi Company )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022